You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)

The agreement aims to improve patient access to coagulation disorders treatments in Europe

read more 

EVENTS

Kedrion Biopharma initiatives for World Hemophilia Day 2017

The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over

read more 

PLASMA & BIOTHERAPIES

Article by Prof. Farrugia and Daniela Scaramuccia published on “Biologicals”

International medical journal hosts review of contract plasma fractionation dynamics

read more 
  1. CORPORATE - 19-04-2017

    Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)

    The agreement aims to improve patient access to coagulation disorders treatments in Europe

    read more 
  2. EVENTS - 14-04-2017

    Kedrion Biopharma initiatives for World Hemophilia Day 2017

    The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over

    read more 
  3. CORPORATE - 24-03-2017

    New company AO Kirov Plasma established in Russia

    It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard

    read more 
  4. PLASMA & BIOTHERAPIES - 22-03-2017

    Article by Prof. Farrugia and Daniela Scaramuccia published on “Biologicals”

    International medical journal hosts review of contract plasma fractionation dynamics

    read more 

Pages

For more information please contact: pressoffice@kedrion.com